In the Conversation
The leaders.
Faculty announced in cadence with the programme.
the circle. forum · BILS 2027 · Berlin
What scales.
What purifies.
Who manufactures the future.
Less noise. More signal.
01
Every biologics leader is asked the same question. How does discovery become medicine — at scale, with the platform that holds. The infrastructure between candidate and patient is being rebuilt.
02
The white space is the room that holds the conversation differently. Closed-door. By invitation. End-user led. No expo hall. No vendor pitch. A circle for the leaders building what comes next.
03
the Annual. BILS is that room. Senior biologics leadership convened around the work that compounds — upstream, downstream, CDMO, digital manufacturing and supply. Less noise. More signal.
04
In the room. Previously confirmed for 2027: Jens H. Vogel, SVP & Head of Global Biologics Operating Unit, MSD. Further faculty announced in cadence with the programme.
Bio Innovation Leaders Summit 2027
For decision makers from small biotech to large pharma.
The gap.
Biology moves faster than the infrastructure designed to carry it. Process validation still needs a human signature. The recommendation behind it is now algorithmic. Viral safety clearance follows predictive models. Sterile filtration integrity is monitored by systems that outrun the operator. The compliance gap between model output and accountability has never been formally named.
The Annual.
BILS convenes the leaders building the infrastructure that closes that gap — across upstream bioprocessing, downstream purification, CDMO strategy, digital manufacturing and supply chain. The corridor where biologics ambition becomes clinical supply · or breaks. The Annual is where the leaders who carry the accountability meet before the inspection does.
The decision.
What scales. What purifies. Who manufactures the future. Three questions the room must hold before the process locks. For the leaders who own the plant, sign the batch and are accountable for the intelligence layer no one has formally governed.
Faculty announced in cadence with the programme.
"
Not an event. It is a tradition.
Uwe Gottschalk · Former CSO Lonza · Operating Partner, Keensight Capital
By invitation. By relevance. By room.
Up to
150
senior leaders
Ratio
80/20
end-user · partner
Format
Two
days
closed-door
Seniority
70%+
named principals
By invitation. By relevance. By room.
Invited · By Role
Invited · By Organisation
BILS 2027 · Berlin.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
in the room.
the circle. forum · Partner Positions
Partner packages and investment are shared directly.
Enter your access code to continue.
No access code? Request the prospectus →
Not the forum. The relationship.
Q 1
The briefing.
Pre-forum strategic briefing. The room. The roster. The reason.
Q 2
The forum.
BILS held inside each forum of the Annual. Two days. Closed-door. End-user led.
Q 3
The follow.
Named delegate follow-through. Curated meeting introductions.
Q 4
The intelligence.
Quarterly intelligence briefing from the Annual Team.
A position. Not a placement.
the circle. · access
The prospectus is not public. It is shared directly with the organisations that belong in the room. Leave your details and we'll send it to you.
"Not an event. It is a tradition."
Uwe Gottschalk · Former CSO Lonza · Operating Partner Keensight Capital
By invitation. By relevance. By room.
The room. The conversations. The decisions.
